Status:
COMPLETED
Nexium RESPONSE Trial
Lead Sponsor:
AstraZeneca
Conditions:
GERD
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The primary purpose of the study is to develop, and test, an algorithm for identification of responders to empirical esomeprazole treatment in general practices.
Eligibility Criteria
Inclusion
- Patients attending general practice due to symptoms suggestive of acid related disease and, according to normal routine, the GP would prescribe an acid-inhibiting agent
Exclusion
- Alarm symptoms
- Pregnancy
- Contraindications to Nexium
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2007
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00318968
Start Date
May 1 2006
End Date
November 1 2007
Last Update
January 26 2009
Active Locations (38)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aabenraa, Denmark
2
Research Site
Aalborg, Denmark
3
Research Site
Albek, Denmark
4
Research Site
Ans, Denmark